Non secretory multiple myeloma involving the maxilla: Report of a case with update of biology and new approaches to management

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 2, 1997, Pages 136-140

  Gray, S T ^a   Antunovic, D M ^a   White, A E ^a  

^a TARANAKI BASE HOSPITAL   (New Zealand)

Author keywords

Biology; Dental; Management; Myeloma; Oral

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HEAD AND NECK CANCER; HUMAN; MAXILLA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HUMANS; MAXILLARY NEOPLASMS; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 0031105168     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00045-0     Document Type: Article

References (51)

1. 1. Barlogie, B., Alexanian, R. and Jaganath, S., Plasma cell dyscrasia. Journal of the American Medical Association, 1992, 268, 2946-2951.
2. 2. Zachriades, N., Papanicolaou, S., Papavassiliou, D., Vairaktaris, E., Triantafyllou, D. and Mextis, M., Plasma cell myeloma of the jaws. International Journal of Oral Maxillofacial Surgery, 1987, 16, 510-515.
3. 3. Dimopoulos, M. A., Dimopoulos, A., Smith, T., Delasalle, K. B. and Alexanian, R., Risk of disease progression in asymptomatic multiple myeloma. American Journal of Medicine, 1992, 94, 57-61.
4. 4. Macleod, J., Edwards, C. and Bouchier, I., eds. Davidson's Principles and Practice of Medicine. Churchill Livingston, Edinburgh, 1987, 538-541.
5. 5. Glover, G. R., Nesbitt, J. A. and North, A. F., Maxillary plasma cytoma/plasma cell myeloma. Oral Surgery, Oral Medicine, Oral Pathology, 1987, 64, 680-686.
6. 6. Sirois, D. A., Cohen, S. G. and Greenberg, M. S., Maxillofacial plasmacytoma resulting in intraoral haemorrhage in a patient with multiple myeloma. Special Care Dentist, 1991, 11, 158-161.
7. 7. Petit, J. C. and Ripamonti, U., Multiple Myeloma of the periodontium. Journal of Periodontal, 1990, 61, 132-137.
8. 8. Gonzalez, J., Elizondo, J., Trull, J. M. and De Torres, I., Plasma cell tumours of the condyle. British Journal of Oral Maxillofacial Surgery, 1991, 29, 274-276.
9. 9. Flick, W. G. and Lawrence, F. R., Oral amyloidosis as initial symptoms of multiple myeloma. Oral Surgery, Oral Medicine, Oral Pathology, 1980, 49, 18-20.
10. 10. Lewin, R. W. and Cataldo, E., Multiple myeloma discovered from oral manifestations: report of a case. Journal of Oral Surgery, 1967, 25, 68-72.
11. 11. Henderson, D. and Rowe, N. L., Myelomatosis affecting the jaws. British Journal of Oral Surgery, 1968, 6, 161-171.
12. 12. Epstein, J. B., Voss, N. J. S. and Stevenson-Moore, P., Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, 1984, 57, 267-271.
13. 13. Raubenheimer, E. F., Dauth, J. and de Coning, J. P., Multiple myeloma presenting with extensive oral and perioral amyloidosis. Oral Surgery, Oral Medicine, Oral Pathology, 1986, 61, 492-497.
14. 14. Moss, R. L., Multiple myeloma with maxillary myelomatous epulis and malignant pheochromocytoma. Report of a case. Oral Surgery, Oral Medicine, Oral Pathology, 1958, 11, 951-959.
15. 15. Lambertenghi-Deliliers, G., Bruno, E., Cortelezzi, A., Fumagalli, L. and Morosini, A., Incidence of jaw lesions in 193 patients with multiple myeloma. Oral Surgery, Oral Medicine, Oral Pathology, 1988, 65, 533-537.
16. 16. Maharaj, B., Kalideen, J. M., Leary, W. P. and Pudifin, D. J., Carcinoma of the prostate with multiple osteolytic metasis simulating multiple myeloma. South African Medical Journal, 1986, 70, 227-228.
17. 17. Kyle, R. A., Multiple myeloma: review of 869 cases. Mayo Clinic Proceedings, 1975, 50, 29-40.
18. 18. Snapper, I., ed. Bone Diseases in Medical Practice. Grune and Stratton, New York, 1957, 157-168.
19. 19. Sommer, I., Knobel, B., Meytes, D. and Siedel, L., Coexistence of non-secreting and non-producing light chain multiple myeloma. Acta Haematologica, 1985, 73, 173-175.
20. 20. Cereda, J. M., Ayers, J. and Gibson, T., Non-excretory myeloma. British Medical Journal, 1982, 285, 715-716.
21. 21. Monje, F., Gil-Diez, J. L., Campano, F. J. and Alonso, del Hoyo J. R., Mandibular lesion as the first evidence of multiple myeloma. Journal of Cranio Maxillo Facial Surgery, 1989, 17, 315-317.
22. 22. Serre, H., Cazal, and Jaffiol, G, Plasmacytome multiple a forme osseuse pure sans dysprotidemie et sans proteinurie. Bull Soc Med Hop Paris, 1958, 74, 191-195.
23. 23. Ozaki, M. and Yamanaka, H., An unusual case of Bence-Jones myeloma with extremely low levels of monoclonal immunoglobulin. Oral Surgery, Oral Medicine, Oral Pathology, 1986, 61, 498-503.
24. 24. Kim, I., Harley, J. B. and Weksler, B., Multiple myeloma without initial paraproteins. American Journal of Medical Sciences, 1972, 264, 267-275.
25. 25. Durie, B. G. M., The plasma cell disorders. In Kelly WN, ed. Testbook of Internal Medicine. JB Lippincott, New York, 1989, 184-187.
26. 26. Raubenheimer, E. J., Dauth, J. and Senekal, J. C., Non-secretory IgA Kappa myeloma with distended endoplasmic reticulum: a case report. Histopathology, 1991, 19, 380-382.
27. 27. Epstein, J., Myeloma phenotype: clues to disease origin and manifestation. Hematol Oncol Clin North Am, 1992, 6, 249-256.
28. 28. Barlogie, B., Epstein, J., Selvanayagam, P. and Alexanian, R., Plasma cell myeloma: new biological insights and advances in therapy. Blood, 1989, 73(40), 865-879.
29. 29. Klein, B., Zhang, X. G., Jourdan, M., et al., Paracrine but not autocrine regulation of myeloma-cell growth and differentiation by interleuken-6. Blood, 1989, 73, 517-526.
30. 30. Calligaris-Cappio, F., Gregoretti, M. G., Ghia, P. and Bergui, L., In vitro growth of human multiple myeloma: implication for biology and therapy. Hematol Oncol Clin North Am, 1992, 6, 257-271.
31. 31. Klein, B. and Bataille, R., Cytokine network in multiple myeloma. Hematol Oncol Clin North Am, 1992, 6, 273-284.
32. 32. Durie, B. G. M., Cellular and molecular genetic features of myeloma and related disorders. Hematol Oncol Clin North Am, 1992, 6, 463-477.
33. 33. Weinstein, R. S., Bone involvement in multiple myeloma. Americal Journal of Medicine, 1992, 93, 591-594.
34. 34. Bataille, R., Chappard, D. and Klein, B., Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am, 1992, 6, 285-295.
35. 35. Valentin-Opran, A., Carhon, S. A., Meunier, P. J., Edouard, C. M. and Arlot, M. E., Quantitative histology of myeloma-induced bone changes. British Journal of Haemotology, 1982, 52, 601-610.
36. 36. Stashenko, P., Dewhirst, F. E., Rooney, M. L., Desjardins, L. A. and Heeley, J. D., Interleukin-1-beta is a potent inhibitor of bone formation in vitro. Journal of Bone and Mineral Research, 1987, 2, 559-565.
37. 37. Kyle, R. A., Long term survival in multiple myeloma. New England Journal of Medicine, 1983, 308, 314-316.
38. 38. Anderson, K. C., Barut, B. B., Ritz, J. J., et al., Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood, 1991, 77, 1712-1722.
39. 39. Mandelli, F., Avvisati, G., Amadori, S., et al., Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. New England Journal of Medicine, 1990, 322, 1430-1434.
40. 40. van Breudelen, F. M. J.; Bijvoet, O. L. M. and van Oosterom, A. T., Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD). Lancet, 1979, 1, 803-805.
41. 41. Mandelli, F., Avvisati, G. and Tribalto, M., Biology and treatment of multiple myeloma. Current Opinions in Oncology, 1992, 4, 73-86.
42. 42. Klein, B., Wijdenes, J., Zhang, X. G., et al., Murine anti-interleukin-6 monoclonal antibody therapy in myeloma. Blood, 1991, 78, 1198-1204.
43. 43. Hibi, M., Marukami, M., Saito, M., Hirano, T. and Kishimoto, T., Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell, 1990, 63, 1149-1157.
44. 44. Dunbar, C. E. and Nienhius, A. W., Multiple myeloma-new approaches to therapy. JAMA, 1993, 269, 2412-2416.
45. 45. Mariette, X., Khalifa, P., Ravaud, P., Frija, J., et al., Bone density in patients with multiple myeloma. Americal Journal of Medicine, 1992, 93, 595-598.
46. 46. van Wowern, N., Klausen, B. and Kollerup, G., Osteoporosis: a risk factor in periodontal disease. J Periodontal, 1994, 65, 1134-1138.
47. 47. Sager, R. D. and Theis, R. M., Dental implants placed in a patient with multiple myeloma: report of case. Journal of the American Dental Association, 1990, 121, 669-701.
48. 48. Krutchkoff, D. J. and Eisenberg, E., Dying of cancer: a patients recollection of her illness and of her doctors. Oral Surgery, Oral Medicine, Oral Pathology, 1991, 71, 401-406.
49. 49. Scully, C., Systemic diseases of particular importance in dentistry. In Patient Care - a Dental Surgeon's Guide. British Dental Journal, London, 1989, 85-90.
50. 50. Cawson, R. A., Effects of radiation on the mouth and jaws and radiation hazards in dentistry. In Essentials of Dental Surgery and Pathology. 4th edn. Churchill Livingstone, Edinburgh, 1984, 398-407.
51. 51. Sciubba, J., Beckert, C., Curro, F., et al., National Institutes of Health consensus development conference statement: oral complications of cancer therapies, diagnosis, prevention and treatment. Journal of the American Dental Association, 1989, 119, 179-183.